Genetic testing for hereditary tumors includes 90 genes related to 25 types of hereditary tumors reported in authoritative guidelines, databases and literature research (For men: 90 genes for 23 hereditary tumors; For women: 85 genes for 24 hereditary tumors), and determines the pathogenicity of the detected variations according to the guidelines of the American College of Medical Genetics and Genomics (ACMG). Ultimately, it helps in the risk assessment of hereditary tumors and promotes the early screening, diagnosis and treatment of tumors.
High efficiency and accuracy
Authoritative guidance
Convenient operation
Tumor patients: High-incidence hereditary tumor types such as breast cancer, ovarian cancer, colorectal cancer, etc. Early age of onset; Multiple lesions or multiple primary malignant tumors in the same person; Special types of tumors (such as male breast cancer); There is a family history of tumors.
People with family history of tumors: Multiple relatives have the same or similar tumors; The tumor involves at least two consecutive generations of relatives. There are young or special types of tumor patients in the family.
General population: all people who care about health.
For cancer patients: it helps cancer patients to identify genetic causes and assists clinicians in precise diagnosis and treatment. It indicates the prognosis of tumors and predicts the risk of developing other tumors.
For people with a family history of tumors and the general population: it indicates the risk of developing hereditary tumors. Screen out high-risk groups and strengthen subsequent health management in a targeted manner.
Informed consent
Sample collection
Nucleic acid extraction
Library preparation
Next generation sequencing
Bioinformatics analysis
Data interpretation
Report distribution
15 working days after receiving qualified samples.